Christopher B Ehrlich Phoenix Biotech Acquisition Corp. (PBAXU) insider trading activity

PBAXU Quotes by TradingView

Christopher B Ehrlich is Interim Chairman and CEO of PHOENIX BIOTECH ACQUISITION CORP.. Currently has a direct ownership of 5.79 Million shares of PBAXU, which is worth approximately $0. The most recent transaction as insider was on Sep 25, 2024, when has been sold 5,312,983 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.79M
1109.59% 3M change
n/a 12M change
Total Value Held $0

Christopher B Ehrlich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 25 2024
BUY
Exercise of conversion of derivative security
-
5,312,983 Added 47.84%
5,791,808 Common Stock
Feb 14 2024
BUY
Other acquisition or disposition
-
478,825 Added 50.0%
478,825 Common Stock

Also insider at

EFTR
eFFECTOR Therapeutics, Inc. Healthcare
CBE

Christopher B Ehrlich

Interim Chairman and CEO
Solana Beach, CA

Track Institutional and Insider Activities on PBAXU

Follow PHOENIX BIOTECH ACQUISITION CORP. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PBAXU shares.

Notify only if

Insider Trading

Get notified when an Phoenix Biotech Acquisition Corp. insider buys or sells PBAXU shares.

Notify only if

News

Receive news related to PHOENIX BIOTECH ACQUISITION CORP.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PBAXU